Es gab 50 kürzliche Insider-Transaktionen für Science 37 Holdings, Inc. (SNCE), darunter 16 Käufe und 32 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $22.15M und die gesamten Insider-Verkäufe auf $55.55M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Pellizzari Christine A, Von Autenried Paul, Hubbard John W. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — SNCE
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-03-12 |
Pellizzari Christine A |
Chief Legal and HR Officer |
Aktienrückgabe |
428 |
- |
- |
- |
| 2024-03-12 |
Von Autenried Paul |
Other: Former Director |
Übernahmeangebot (Verkauf) |
2,302 |
$5.75 |
$13.24K |
- |
| 2024-03-12 |
Hubbard John W |
Other: Former Director |
Aktienrückgabe |
20,195 |
$5.51 |
$111.27K |
- |
| 2024-03-12 |
Rollins Emily |
Other: Former Director |
Aktienrückgabe |
1,378 |
$201.00 |
$276.98K |
- |
| 2024-03-12 |
Zaranek Mike |
Chief Financial Officer |
Aktienrückgabe |
45,746 |
$5.60 |
$256.18K |
- |
| 2024-03-12 |
Cotliar Jonathan |
Chief Medical Officer |
Aktienrückgabe |
7,944 |
$8.00 |
$63.55K |
- |
| 2024-03-12 |
Coman David |
Officer, Other: Chief Executive Officer |
Aktienrückgabe |
192,427 |
$5.60 |
$1.08M |
- |
| 2024-03-12 |
Forman Darcy |
Chief Delivery Officer |
Aktienrückgabe |
3,404 |
$5.51 |
$18.76K |
- |
| 2024-03-12 |
Tiwari Neil |
Other: Former Director |
Aktienrückgabe |
1,378 |
$201.00 |
$276.98K |
- |
| 2024-03-12 |
Shipton Michael |
Chief Commercial Officer |
Aktienrückgabe |
52,168 |
- |
- |
- |
| 2024-03-12 |
Redmile Group, Llc |
Other: Former 10% Owner and Director |
Aktienrückgabe |
95,765 |
- |
- |
- |
| 2024-03-12 |
Faulkner Robert C. |
Other: Former Director |
Aktienrückgabe |
2,068 |
$201.00 |
$415.67K |
- |
| 2024-03-12 |
Thermo Fisher Scientific Inc. |
10 Percent Owner |
Übernahmeangebot (Verkauf) |
868,990 |
$5.75 |
$5M |
- |
| 2024-03-10 |
Shipton Michael |
Chief Commercial Officer |
RSU-Steuereinbehalt |
3,006 |
$5.73 |
$17.22K |
9,247 |
| 2023-10-07 |
Shipton Michael |
Chief Commercial Officer |
RSU-Steuereinbehalt |
29,201 |
$0.41 |
$11.93K |
70,799 |
| 2023-08-12 |
Pellizzari Christine A |
Chief Legal and HR Officer |
Optionsausübung (Verkauf) |
355,549 |
- |
- |
711,097 |
| 2023-08-12 |
Zaranek Mike |
Chief Financial Officer |
Optionsausübung (Verkauf) |
256,207 |
- |
- |
512,414 |
| 2023-08-12 |
Cotliar Jonathan |
Chief Medical Officer |
Optionsausübung (Verkauf) |
230,882 |
- |
- |
461,764 |
| 2023-08-12 |
Coman David |
Chief Executive Officer |
Optionsausübung (Verkauf) |
495,122 |
- |
- |
990,243 |
| 2023-08-12 |
Forman Darcy |
Chief Delivery Officer |
Optionsausübung (Verkauf) |
288,972 |
- |
- |
577,942 |
| 2023-05-19 |
Pellizzari Christine A |
Chief Legal and HR Officer |
Optionsausübung (Verkauf) |
16,667 |
- |
- |
33,333 |
| 2023-05-11 |
Von Autenried Paul |
Director |
Optionsausübung (Verkauf) |
46,040 |
- |
- |
- |
| 2023-05-11 |
Hubbard John W |
Director |
Optionsausübung (Verkauf) |
40,983 |
- |
- |
- |
| 2023-05-11 |
Rollins Emily |
Director |
Optionsausübung (Verkauf) |
40,983 |
- |
- |
- |
| 2023-05-11 |
Tiwari Neil |
Director |
Optionsausübung (Verkauf) |
40,983 |
- |
- |
- |
| 2023-05-11 |
Shipton Michael |
Chief Commercial Officer |
RSU-Zuteilung |
494,853 |
- |
- |
494,853 |
| 2023-05-11 |
Bryenton Troy |
Chief Technology Officer |
Veräußerung |
522,793 |
- |
- |
- |
| 2023-05-11 |
Bryenton Troy |
Chief Technology Officer |
RSU-Zuteilung |
494,853 |
- |
- |
494,853 |
| 2023-05-11 |
Redmile Group, Llc |
10 Percent Owner |
RSU-Zuteilung |
494,853 |
$0.25 |
$125K |
20,344,070 |
| 2023-05-11 |
Faulkner Robert C. |
Director |
RSU-Zuteilung |
494,853 |
$0.25 |
$125K |
535,836 |
| 2023-04-28 |
Pellizzari Christine A |
Chief Legal and HR Officer |
Aktienrückgabe |
247,000 |
$10.05 |
$2.48M |
- |
| 2023-04-28 |
Zaranek Mike |
Chief Financial Officer |
Aktienrückgabe |
467,351 |
$10.05 |
$4.7M |
- |
| 2023-04-28 |
Cotliar Jonathan |
Chief Medical Officer |
Aktienrückgabe |
200,549 |
$11.47 |
$2.3M |
- |
| 2023-04-28 |
Coman David |
Chief Executive Officer |
Aktienrückgabe |
557,692 |
$11.47 |
$6.4M |
- |
| 2023-04-28 |
Forman Darcy |
Chief Delivery Officer |
Aktienrückgabe |
1,020,754 |
$10.05 |
$10.26M |
- |
| 2023-03-10 |
Shipton Michael |
Chief Commercial Officer |
RSU-Zuteilung |
522,793 |
- |
- |
522,793 |
| 2022-11-17 |
Pellizzari Christine A |
Chief Legal Officer |
Informierter Kauf |
5,000 |
$0.81 |
$4.03K |
5,000 |
| 2022-10-07 |
Von Autenried Paul |
Director |
RSU-Zuteilung |
46,040 |
- |
- |
46,040 |
| 2022-10-07 |
Shipton Michael |
Chief Commercial Officer |
RSU-Zuteilung |
300,000 |
- |
- |
300,000 |
| 2022-09-30 |
Von Autenried Paul |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-09-12 |
Shipton Michael |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-08-12 |
Pellizzari Christine A |
Chief Legal Officer |
RSU-Zuteilung |
1,066,646 |
- |
- |
1,066,646 |
| 2022-08-12 |
Zaranek Mike |
Chief Financial Officer |
RSU-Zuteilung |
768,621 |
- |
- |
768,621 |
| 2022-08-12 |
Geffon Steven |
Chief Commercial Officer |
RSU-Zuteilung |
563,414 |
- |
- |
563,414 |
| 2022-08-12 |
Cotliar Jonathan |
Chief Medical Officer |
RSU-Zuteilung |
692,646 |
- |
- |
692,646 |
| 2022-08-12 |
Coman David |
Chief Executive Officer |
RSU-Zuteilung |
1,485,365 |
- |
- |
1,485,365 |
| 2022-08-12 |
Forman Darcy |
Chief Delivery Officer |
RSU-Zuteilung |
866,914 |
- |
- |
866,914 |
| 2022-06-29 |
Forman Darcy |
Chief Delivery Officer |
Optionsausübung |
68,075 |
$0.28 |
$19.06K |
110,456 |
| 2022-06-13 |
Redmile Group, Llc |
10 Percent Owner |
Sonstige (Kauf) |
6,472,228 |
$3.38 |
$21.88M |
19,849,217 |
| 2022-06-13 |
Green Jeremy |
Director |
Sonstige (Verkauf) |
6,472,228 |
$3.38 |
$21.88M |
19,849,217 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
